Literature DB >> 10367355

Rabbit EPEC: a model for the study of enteropathogenic Escherichia coli.

A Milon1, E Oswald, J De Rycke.   

Abstract

Colibacillosis has become, in rational rabbit breeding units of western Europe, one of the most economically and pathologically important issues since the beginning of the 1980s. Data on the virulence mechanisms and the phenotypic characters of the E. coli strains that are responsible for lethal diarrhoea epizootics have been gathered throughout the years. These strains are representative of a pathovar called enteropathogenic E. coli (EPEC) in diarrhoeagenic strains of human origin. EPEC are mainly characterized by their ability to induce a typical lesion called attachment/effacement, whose determinism lies in a pathogenicity island: the locus of enterocyte effacement. The understanding of the pathogenesis mechanisms of this type of bacteria should lead to new tools helping to control the disease in rabbit farming.

Entities:  

Mesh:

Year:  1999        PMID: 10367355

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  26 in total

1.  Feedback effects of host-derived adenosine on enteropathogenic Escherichia coli.

Authors:  John K Crane; Irina Shulgina
Journal:  FEMS Immunol Med Microbiol       Date:  2009-08-18

2.  The RpoE Stress Response Pathway Mediates Reduction of the Virulence of Enteropathogenic Escherichia coli by Zinc.

Authors:  Yuan Xue; Jossef Osborn; Anand Panchal; Jay L Mellies
Journal:  Appl Environ Microbiol       Date:  2015-03-27       Impact factor: 4.792

3.  Characterization of monkey enteropathogenic Escherichia coli (EPEC) and human typical and atypical EPEC serotype isolates from neotropical nonhuman primates.

Authors:  Vania M Carvalho; Carlton L Gyles; Kim Ziebell; Marcela A Ribeiro; José L Catão-Dias; Idércio L Sinhorini; Jamile Otman; Rogéria Keller; Luiz R Trabulsi; Antônio F Pestana de Castro
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

4.  Control of bacterial virulence by the RalR regulator of the rabbit-specific enteropathogenic Escherichia coli strain E22.

Authors:  Yogitha N Srikhanta; Dianna M Hocking; Matthew J Wakefield; Ellen Higginson; Roy M Robins-Browne; Ji Yang; Marija Tauschek
Journal:  Infect Immun       Date:  2013-09-03       Impact factor: 3.441

5.  Biological Activities of Uric Acid in Infection Due to Enteropathogenic and Shiga-Toxigenic Escherichia coli.

Authors:  John K Crane; Jacqueline E Broome; Agnieszka Lis
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

6.  Predominance of afr2 and ral fimbrial genes related to those encoding the K88 and CS31A fimbrial adhesins in enteropathogenic Escherichia coli isolates from rabbits with postweaning diarrhea in Central Europe.

Authors:  Mohamed A Dow; István Tóth; Pavel Alexa; Michael Davies; Anna Malik; Eric Oswald; Béla Nagy
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Role of host xanthine oxidase in infection due to enteropathogenic and Shiga-toxigenic Escherichia coli.

Authors:  John K Crane; Tonniele M Naeher; Jacqueline E Broome; Edgar C Boedeker
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

8.  RegR virulence regulon of rabbit-specific enteropathogenic Escherichia coli strain E22.

Authors:  Yogitha N Srikhanta; Dianna M Hocking; Judyta Praszkier; Matthew J Wakefield; Roy M Robins-Browne; Ji Yang; Marija Tauschek
Journal:  Infect Immun       Date:  2013-01-22       Impact factor: 3.441

9.  2F3 monoclonal antibody recognizes the O26 O-antigen moiety of the lipopolysaccharide of enterohemorrhagic Escherichia coli strain 4276.

Authors:  I M Szalo; B Taminiau; F Goffaux; V Pirson; J McCappin; H J Ball; J G Mainil
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

10.  Comparative analysis of the locus of enterocyte effacement and its flanking regions.

Authors:  Daniel Müller; Inga Benz; Ariane Liebchen; Inka Gallitz; Helge Karch; M Alexander Schmidt
Journal:  Infect Immun       Date:  2009-06-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.